PTEN-mediated mechanism of immune resistance to anti-PD-1 therapy was also confirmed in a case report from a chemotherapy-naïve patient with rapidly-progressive metastatic uterine leiomyosarcoma who experienced complete tumor remission for > 2 years on anti-PD-1 monotherapy [26]. The gene discussed is PTEN; the disease is neoplasm.